Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis

Update on NAFLD genetics: from new variants to the clinic

(2020) Eric Trépo et al.   JOURNAL OF HEPATOLOGY

Interactions between gut microbiota and non-alcoholic liver disease: the role of microbiota-derived metabolites

(2019) Yufang Ding et al.   PHARMACOLOGICAL RESEARCH

Metabolomic Salivary Signature of Pediatric Obesity Related Liver Disease and Metabolic Syndrome

(2019) Jacopo Troisi et al.   Nutrients

Hepatic metabolic adaptation in a murine model of glutathione deficiency

(2019) Ying Chen et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Use of a metabolomic approach to non-invasively diagnose non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus

(2018) Fernando Bril et al.   DIABETES OBESITY & METABOLISM

What’s in metabolomics for alcoholic liver disease?

(2018)   Journal of Gastrointestinal and Liver Diseases

Is cryptogenic cirrhosis different from NASH cirrhosis?

(2018) Paul J. Thuluvath et al.   JOURNAL OF HEPATOLOGY

Metabolomic Signature of Endometrial Cancer

(2018) Jacopo Troisi et al.   JOURNAL OF PROTEOME RESEARCH

A metabolomics-based approach for non-invasive screening of fetal central nervous system anomalies

(2018) Jacopo Troisi et al.   Metabolomics

Family history and obesity in youth, their effect on acylcarnitine/aminoacids metabolomics and non-alcoholic fatty liver disease (NAFLD). Structural equation modeling approach

(2018) Maria Elena Romero-Ibarguengoitia et al.   PLoS One

High dietary intake of branched-chain amino acids is associated with an increased risk of insulin resistance in adults

(2018) Golaleh Asghari et al.   Journal of Diabetes

Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance

(2017) Melania Gaggini et al.   HEPATOLOGY

A metabolomics-based approach for non-invasive diagnosis of chromosomal anomalies

(2017) Jacopo Troisi et al.   Metabolomics

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

(2017) Zobair Younossi et al.   Nature Reviews Gastroenterology & Hepatology

Urinary Metabolomics in Pediatric Obesity and NAFLD Identifies Metabolic Pathways/Metabolites Related to Dietary Habits and Gut-Liver Axis Perturbations

(2017) Jacopo Troisi et al.   Nutrients

Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy

(2017) Junli Ma et al.   Nutrients

Identification of key metabolic changes during liver fibrosis progression in rats using a urine and serum metabolomics approach

(2017) Hong Chang et al.   Scientific Reports

The role of the gut microbiota in NAFLD

(2016) Christopher Leung et al.   Nature Reviews Gastroenterology & Hepatology

The Relationship between Branched-Chain Amino Acid Related Metabolomic Signature and Insulin Resistance: A Systematic Review

(2016) Xue Zhao et al.   Journal of Diabetes Research

Antioxidant Mechanisms in Nonalcoholic Fatty Liver Disease

(2015) Wensheng Liu et al.   CURRENT DRUG TARGETS

Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: One stone hits two birds

(2015) Chengfu Xu et al.   JOURNAL OF HEPATOLOGY

Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology

(2015) Nahum Calvo   WORLD JOURNAL OF GASTROENTEROLOGY

Metabolomics of alcoholic liver disease: a clinical discovery study

(2015) Qun Liang et al.   RSC Advances

GC-MS Based Plasma Metabolomics for Identification of Candidate Biomarkers for Hepatocellular Carcinoma in Egyptian Cohort

(2015) Mohammad R. Nezami Ranjbar et al.   PLoS One

Branched chain amino acid metabolism profiles in progressive human nonalcoholic fatty liver disease

(2014) April D. Lake et al.   AMINO ACIDS

Deciphering non-alcoholic fatty liver disease through metabolomics: Figure 1

(2014) Ainara Cano et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

Serum Oxidative Stress Markers and Lipidomic Profile to Detect NASH Patients Responsive to an Antioxidant Treatment: A Pilot Study

(2014) Paola Stiuso et al.   Oxidative Medicine and Cellular Longevity

Pathophysiology of NASH: Perspectives for a Targeted Treatment

(2013) Fabio Marra et al.   CURRENT PHARMACEUTICAL DESIGN

World Medical Association Declaration of Helsinki

(2013)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Association Between Nonalcoholic Fatty Liver Disease and Risk for Hepatocellular Cancer, Based on Systematic Review

(2012) Donna L. White et al.   Clinical Gastroenterology and Hepatology

The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

(2012) Naga Chalasani et al.   HEPATOLOGY

Metabolomics: the apogee of the omics trilogy

(2012) Gary J. Patti et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Metscape 2 bioinformatics tool for the analysis and visualization of metabolomics and gene expression data

(2011) Alla Karnovsky et al.   BIOINFORMATICS

Nonalcoholic fatty liver disease activity score and Brunt's pathologic criteria for the diagnosis of nonalcoholic steatohepatitis: What do they mean and do they agree?

(2011) Stefano Ballestri et al.   HEPATOLOGY

Plasma metabolomic profile in nonalcoholic fatty liver disease

(2010) Satish C. Kalhan et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Pathology of nonalcoholic fatty liver disease

(2010) Elizabeth M. Brunt   Nature Reviews Gastroenterology & Hepatology

Fatty Acids, Insulin Resistance, and Protein Metabolism

(2009) Satish C. Kalhan   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM